Clinical Trials
9 trialsNCT04489719 2026-02-17
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
University of Washington
Recruiting
NCT03315260 2024-02-08
Treatment Satisfaction With Ra-223 in Japan
Bayer
Completed
NCT04256993 2024-01-16
PRECISE
Bayer
Completed
NCT04681144 2023-10-26
QOLRAD
Bayer
Completed
NCT04281147 2022-06-23
REACTIVATE
Bayer
Completed
NCT03419442 2020-10-22
Multi-academic Center Study of Xofigo Patients
Bayer
Completed
NCT03325127 2018-10-31
Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study
Bayer
Withdrawn
NCT02518698 2018-09-18
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population
Bayer
Completed
NCT02729103 2018-01-25
Treatment Patterns in Metastatic Prostate Cancer
Bayer
Completed